Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis.
Antoine BouéFlorence JolyJustine LequesneMarie LangePublished in: Cancer (2024)
There is no consensus on the cognitive impairment induced by hormone therapy for prostate cancer, despite the implications for patients' care and daily life. This synthesis of published studies demonstrated an increase in perceived cognitive difficulties but did not prove a decline in cognitive performance during treatment.
Keyphrases
- prostate cancer
- cognitive impairment
- radical prostatectomy
- end stage renal disease
- physical activity
- healthcare
- newly diagnosed
- ejection fraction
- prognostic factors
- mental health
- depressive symptoms
- stem cells
- multiple sclerosis
- randomized controlled trial
- quality improvement
- mild cognitive impairment
- white matter
- patient reported outcomes